カテゴリー： Transparency Market Research, 世界, 医療/バイオ

ポイントオブケア（POC）グルコース検査の世界市場2022～2032：種類別、検査部位別、エンドユーザー別、地域別

◆英語タイトル：Global Point-of-Care Glucose Testing Market by Type (Freestyle Lite, Accu-Chek Inform II, StatStrip, Onetouch Verio Flex, Accu Check Aviva Meter, True Metrix, Bayer CONTOUR Blood Glucose Monitoring System, i-STAT and Other Product Type), by Testing Site (Fingertip Testing and Alternate Site Testing), by end users (Professional Diagnostic Centres, Hospitals & Clinics, home care settings, and Research labs) and Region - 2022 to 2032

Transparency Market Researchが発行した調査報告書（TMR23FB016）◆商品コード：TMR23FB016
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2022年12月30日
◆ページ数：250
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社は、2022年に38億ドルであった世界のポイントオブケア（POC）グルコース検査市場規模が2032年には58億ドルまで拡大し、予測期間中にCAGR 4.3％増加すると見込んでいます。本資料では、ポイントオブケア（POC）グルコース検査の世界市場を総合的に調査・分析を行い、エグゼクティブサマリー、市場概要、市場の背景、ポイントオブケア（POC）グルコース検査の世界市場分析・予測、製品種類別（フリースタイルライト、アキュチェックインフォームII、スタットストリップ、ワンタッチベリオフレックス、その他）分析、エンドユーザー別（専門診断センター、病院・診療所、在宅医療設備、研究所）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競合分析、仮定、調査手法などの内容を調査資料にまとめました。なお、本資料では、F. Hoffmann-La Roche Ltd.、Abbott、Nipro、PlatInium Equity Advisors、Nova Biomedical、ACON Laboratories、Trividia Health、Prodigy Diabetes Care、Bayer AG/Ascensia Diabetes Care Holdings AG、EKF Diagnosticsなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場の背景
・ポイントオブケア（POC）グルコース検査の世界市場分析・予測
・世界のポイントオブケア（POC）グルコース検査市場規模：製品種類別
- フリースタイルライトの市場規模
- アキュチェックインフォームIIの市場規模
- スタットストリップの市場規模
- ワンタッチベリオフレックスの市場規模
- その他ポイントオブケア（POC）グルコース検査の市場規模
・世界のポイントオブケア（POC）グルコース検査市場規模：エンドユーザー別
- 専門診断センターにおける市場規模
- 病院・診療所における市場規模
- 在宅医療設備における市場規模
- 研究所における市場規模
・世界のポイントオブケア（POC）グルコース検査市場規模：地域別
- 北米のポイントオブケア（POC）グルコース検査市場規模
- 中南米のポイントオブケア（POC）グルコース検査市場規模
- ヨーロッパのポイントオブケア（POC）グルコース検査市場規模
- 東アジアのポイントオブケア（POC）グルコース検査市場規模
- 南アジアのポイントオブケア（POC）グルコース検査市場規模
- オセアニアのポイントオブケア（POC）グルコース検査市場規模
- 中東・アフリカのポイントオブケア（POC）グルコース検査市場規模
・市場構造分析
・競合分析
・仮定
・調査手法

Point-of-Care Glucose Testing Market – Scope of Report
TMR’s report on the global point-of-care glucose testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global point-of-care glucose testing market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global point-of-care glucose testing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the point-of-care glucose testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global point-of-care glucose testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global point-of-care glucose testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global point-of-care glucose testing market.

The report delves into the competitive landscape of the global point-of-care glucose testing market. Key players operating in the global point-of-care glucose testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global point-of-care glucose testing market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market point-of-care glucose testing.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
4. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast, 2022-2032
    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
        5.3.1. Freestyle Lite
        5.3.2. Accu-Chek Inform II
        5.3.3. StatStrip
        5.3.4. Onetouch Verio Flex
        5.3.5. Accu Check Aviva Meter
        5.3.6. True Metrix
        5.3.7. Bayer CONTOUR Blood Glucose Monitoring System
        5.3.8. i-STAT
        5.3.9. Other Product Type
    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
        6.3.1. Professional Diagnostic Centres
        6.3.2. Hospital and Clinics
        6.3.3. Home care settings
        6.3.4. Research Lab
    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032
7. Global Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Europe
        7.3.4. East Asia
        7.3.5. South Asia
        7.3.6. Oceania
        7.3.7. MEA
    7.4. Market Attractiveness Analysis By Region
8. North America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        8.2.1. By Country
            8.2.1.1. U.S.
            8.2.1.2. Canada
        8.2.2. By Product Type
        8.2.3. By End User
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Product Type
        8.3.3. By End User
    8.4. Key Takeaways
9. Latin America Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Argentina
            9.2.1.4. Rest of Latin America
        9.2.2. By Product Type
        9.2.3. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product Type
        9.3.3. By End User
    9.4. Key Takeaways
10. Europe Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. Italy
            10.2.1.3. France
            10.2.1.4. U.K.
            10.2.1.5. Spain
            10.2.1.6. Russia
            10.2.1.7. BENELUX
            10.2.1.8. Rest of Europe
        10.2.2. By Product Type
        10.2.3. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product Type
        10.3.3. By End User
    10.4. Key Takeaways
11. East Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        11.2.1. By Country
            11.2.1.1. China
            11.2.1.2. Japan
            11.2.1.3. South Korea
        11.2.2. By Product Type
        11.2.3. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product Type
        11.3.3. By End User
    11.4. Key Takeaways
12. South Asia Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        12.2.1. By Country
            12.2.1.1. India
            12.2.1.2. Thailand
            12.2.1.3. Malaysia
            12.2.1.4. Indonesia
            12.2.1.5. Rest of South Asia
        12.2.2. By Product Type
        12.2.3. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product Type
        12.3.3. By End User
    12.4. Key Takeaways
13. Oceania Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        13.2.1. By Country
            13.2.1.1. Australia
            13.2.1.2. New Zealand
        13.2.2. By Product Type
        13.2.3. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product Type
        13.3.3. By End User
    13.4. Key Takeaways
14. MEA Point-of-Care Glucose Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
        14.2.1. By Country
            14.2.1.1. GCC
            14.2.1.2. Rest of MEA
        14.2.2. By Product Type
        14.2.3. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product Type
        14.3.3. By End User
    14.4. Key Takeaways
15. Key Countries Point-of-Care Glucose Testing Market Analysis
    15.1. U.S.
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2021
            15.1.2.1. By Product Type
            15.1.2.2. By End User
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2021
            15.2.2.1. By Product Type
            15.2.2.2. By End User
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2021
            15.3.2.1. By Product Type
            15.3.2.2. By End User
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2021
            15.4.2.1. By Product Type
            15.4.2.2. By End User
    15.5. Argentina
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2021
            15.5.2.1. By Product Type
            15.5.2.2. By End User
    15.6. Germany
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2021
            15.6.2.1. By Product Type
            15.6.2.2. By End User
    15.7. Italy
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2021
            15.7.2.1. By Product Type
            15.7.2.2. By End User
    15.8. France
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2021
            15.8.2.1. By Product Type
            15.8.2.2. By End User
    15.9. U.K.
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2021
            15.9.2.1. By Product Type
            15.9.2.2. By End User
    15.10. Spain
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2021
            15.10.2.1. By Product Type
            15.10.2.2. By End User
    15.11. Russia
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2021
            15.11.2.1. By Product Type
            15.11.2.2. By End User
    15.12. BENELUX
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2021
            15.12.2.1. By Product Type
            15.12.2.2. By End User
    15.13. China
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2021
            15.13.2.1. By Product Type
            15.13.2.2. By End User
    15.14. Japan
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2021
            15.14.2.1. By Product Type
            15.14.2.2. By End User
    15.15. South Korea
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2021
            15.15.2.1. By Product Type
            15.15.2.2. By End User
    15.16. India
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2021
            15.16.2.1. By Product Type
            15.16.2.2. By End User
    15.17. Thailand
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2021
            15.17.2.1. By Product Type
            15.17.2.2. By End User
    15.18. Malaysia
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2021
            15.18.2.1. By Product Type
            15.18.2.2. By End User
    15.19. Indonesia
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2021
            15.19.2.1. By Product Type
            15.19.2.2. By End User
    15.20. Australia
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2021
            15.20.2.1. By Product Type
            15.20.2.2. By End User
    15.21. New Zealand
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2021
            15.21.2.1. By Product Type
            15.21.2.2. By End User
    15.22. GCC Countries
        15.22.1. Pricing Analysis
        15.22.2. Market Share Analysis, 2021
            15.22.2.1. By Product Type
            15.22.2.2. By End User
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Product Type
        16.3.3. By End User
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. F. Hoffmann-La Roche Ltd.
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
                17.1.1.5.2. Product Strategy
                17.1.1.5.3. Channel Strategy
        17.1.2. Abbott
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
                17.1.2.5.2. Product Strategy
                17.1.2.5.3. Channel Strategy
        17.1.3. Nipro
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
                17.1.3.5.2. Product Strategy
                17.1.3.5.3. Channel Strategy
        17.1.4. PlatInium Equity Advisors
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
                17.1.4.5.2. Product Strategy
                17.1.4.5.3. Channel Strategy
        17.1.5. Nova Biomedical
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
                17.1.5.5.2. Product Strategy
                17.1.5.5.3. Channel Strategy
        17.1.6. ACON Laboratories
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
                17.1.6.5.2. Product Strategy
                17.1.6.5.3. Channel Strategy
        17.1.7. Trividia Health
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
                17.1.7.5.2. Product Strategy
                17.1.7.5.3. Channel Strategy
        17.1.8. Prodigy Diabetes Care
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
                17.1.8.5.2. Product Strategy
                17.1.8.5.3. Channel Strategy
        17.1.9. Bayer AG/Ascensia Diabetes Care Holdings AG
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
                17.1.9.5.2. Product Strategy
                17.1.9.5.3. Channel Strategy
        17.1.10. EKF Diagnostics
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
                17.1.10.5.2. Product Strategy
                17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

List of Tables

Table 1: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 3: Global Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 6: North America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 9: Latin America Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 12: Europe Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 15: East Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 18: South Asia Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 19: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 20: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 21: Oceania Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 22: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 23: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 24: MEA Point-of-Care Glucose Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ポイントオブケア（POC）グルコース検査の世界市場2022～2032：種類別、検査部位別、エンドユーザー別、地域別(Global Point-of-Care Glucose Testing Market by Type (Freestyle Lite, Accu-Chek Inform II, StatStrip, Onetouch Verio Flex, Accu Check Aviva Meter, True Metrix, Bayer CONTOUR Blood Glucose Monitoring System, i-STAT and Other Product Type), by Testing Site (Fingertip Testing and Alternate Site Testing), by end users (Professional Diagnostic Centres, Hospitals & Clinics, home care settings, and Research labs) and Region - 2022 to 2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 吸入装置の世界市場2022～2032：用途別、エンドユーザー別、地域別
  • 自動視野分析器の世界市場2022～2032：製品種類別、エンドユーザー別、地域別
  • 獣医用抗菌剤感受性試験の世界市場2022～2032：製品別、動物別、エンドユーザー別、地域別
  • ウイルスベクター生産の世界市場2022～2032：ワークフロー種類別、ベクター種類別、用途別、エンドユーザー別、地域別
  • 尿比重計の世界市場2022～2032：製品別、用途別、エンドユーザー別

    • ◆H&Iグローバルリサーチのお客様（例）◆